Home > Insider Trading > Filing (0001127602-19-032879)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1613103	Medtronic Plc	MDT	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1233311	J Michael Coyle	710 Medtronic Pkwy Ms Lc300 Minneapolis MN 55432	Evp & Group Pres, Cardiac&Vasc	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Ordinary Shares	Acquisiton	2019-11-14	900	$38.81	189,162	No	4	M	Direct
Ordinary Shares	Disposition	2019-11-14	900	$109.52	188,262	No	4	S	Direct
Ordinary Shares	Acquisiton	2019-11-14	1,202	$41.60	189,464	No	4	M	Direct
Ordinary Shares	Disposition	2019-11-14	1,202	$109.95	188,262	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Ordinary Shares	Stock Option (Right to Buy)	Disposition	2019-11-14	900	$0.00	900	$38.81
Ordinary Shares	Stock Option (Right to Buy)	Disposition	2019-11-14	1,202	$0.00	1,202	$41.60

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
36,874		2022-07-30	No	4	M	Direct
0		2022-10-29	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Ordinary Shares	250	Indirect	By Family Trust
Ordinary Shares	4,104	Indirect	By Spouse

Footnotes

The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $109.50 to $109.61, inclusive. The reporting person undertakes to provide to Medtronic plc , any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes to this Form 4.
This option to purchase 75,548 New Medtronic ordinary shares for $38.81 per share, which was partially vested at the effective time of the Merger, was received in the Merger and represents the conversion of 75,548 Medtronic common stock shares for $38.81 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.
This option to purchase 2,404 New Medtronic ordinary shares for $41.60 per share, which was partially vested at the effective time of the Merger, was received in the Merger and represents the conversion of 2,404 Medtronic common stock shares for $41.60 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.